Robert Z. Orlowski, MD from MD Anderson Cancer Center discusses Ixazomib for maintenance in multiple myeloma and Ixazomib maybe approved by the FDA after trials at the 2017 American Society of Hematology.
Ixazomib for Maintenance In Multiple Myeloma – Ixazomib maybe approved by the FDA after trials
